Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Oncomedics logo — 1 patient - 1 tumour - 1 Oncogramme® - 1 treatment

Oncomedics

1 patient - 1 tumour - 1 Oncogramme® - 1 treatment

Founded 2006 11 employees Angel Biotechnology, Pharmaceutical

General Information

Company Name Oncomedics
Founded Year 2006
Employees 11
Industries Biotechnology, Pharmaceutical
Funding Stage Angel
Social

Get notified when Oncomedics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Oncomedics

Oncomedics is a biotechnology company, part of CliniSciences Group, focusing on personalizing cancer treatments. It develops in vitro diagnostic medical devices to assist surgeons, pathologists, and oncologists in identifying the most effective treatments for individual patients. The company's flagship product, Oncogramme®, evaluates the anti-cancer activity of existing drugs by testing them directly on a patient's operated tumor. This approach, similar to an antibiogram, assesses drug efficacy ex vivo, providing personalized chemotherapy options for patients with stage IV colorectal cancer since 2016. Oncomedics plans to optimize the Oncogramme® for other cancers like breast and ovarian cancer, further enhancing treatment accuracy. Established in 2006, Oncomedics received an Angel Round investment from Limousin Business Angels on 29 November 2017. The company operates in the Biotechnology and Pharmaceutical industries, showing potential for innovative and personalized cancer treatment solutions.

Taxonomy: oncology, personalized medicine, cancer treatments, in vitro diagnostics, tumor testing, chemotherapy, precision medicine, drug efficacy, colorectal cancer, breast cancer, ovarian cancer, ex vivo testing, decision support

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Angel Round •••••• 1
Investor
29 Nov 2017

Oncomedics Alternatives & Competitors

Oncomedics vs
Pear Bio
Pear Bio United Kingdom

Patient-centered cancer precision medicine

Series A
10 employees
Biotechnology, Health Care
Oncomedics vs
ASC Oncology GmbH
ASC Oncology GmbH Germany

RETHINK ONCOLOGY

7 employees
Biotechnology, Health Care
Oncomedics vs
Cancer Center for Healing
Cancer Center for Healing United States

To provide optimal health & longevity to our patients by seeking the most innovative treatments avai...

7 employees
Health Care

FAQ About Oncomedics

1 patient - 1 tumour - 1 Oncogramme® - 1 treatment
Oncomedics was founded in 2006.
Oncomedics operates in the following industries: Biotechnology, Pharmaceutical.
Oncomedics has approximately 11 employees.
Oncomedics has completed 1 funding round. The latest funding stage is Angel.
Top alternatives and competitors to Oncomedics include Pear Bio, ASC Oncology GmbH, Cancer Center for Healing, MetasTx LLC, PrognosDx Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Oncomedics and Pear Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Oncomedics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes